4 ms·
New Alzheimer’s drug slows cognitive decline by 35%, trial results show
- alephxyz 4y agoDo these two new drugs (lecanemab and donanemab) work the same way aducanemab does? Does that mean that the aducanemab results weren't a fluke and that the amyloid plaque hypothesis may in fact be true?
- zosima 4y agoYes, Aducanumab may very well have had mild efficacy in the high dose group. But clearly the two newer drugs appear superior. Especially, when considering the side-effect profile. It will be exciting to see how efficacious these amyloid-beta antibodies can become and there is also clearly a small mystery (or at least a lack of consensus) in why the newer drugs show efficacy and the previous ones all failed.
- DANmode 4y agoIs plaque potentially 'just" a severely complicating factor more than a cause?
- loo 4y agoMaybe it's like "low serotonin levels" is to depression. A mechanism through which some effects are expressed, but not the root cause, and only one aspect of the condition.